CytoSorbents Corporation 8-K Report: Key Corporate Update for January 2025
Based on the provided excerpt from the financial report, here are the key pieces of information and insights:
- Entity Information:
- Name: CytoSorbents Corporation
- Location: 305 College Road East, Princeton, NJ 08540
- Contact Number: 732-329-8885
- CIK Number: 0001175151
- SEC Filing Type: 8-K
- SEC File Number: 001-36792
- EIN: 98-0373793
- Stock Information:
- Common Stock Par Value: $0.001
- Ticker Symbol: CTSO
- Exchange: NASDAQ
- Filing Date:
- Date of Report: January 3, 2025
- Context and Measurement Units:
- The report is structured using the XBRL (eXtensible Business Reporting Language) format, which is standard for SEC filings.
- Measurement Units:
- Financial figures are reported in USD (United States Dollar).
- Shares are reported as a unit of measurement for equity.
- Period of Report:
- The report covers a specific date: January 3, 2025.
Insights:
- The filing is an 8-K, which typically reports unscheduled material events or corporate changes that are important to shareholders. This could indicate a significant event for CytoSorbents Corporation on this date.
- The information suggests that the company is actively filing reports with the SEC, which is a positive indicator of transparency and regulatory compliance.
- The low par value of the common stock ($0.001) is typical for many companies, particularly those in early growth stages or in biotech sectors, suggesting potential volatility in stock price.
Overall, this filing provides a snapshot of CytoSorbents Corporation’s current status and recent activity as of early January 2025.